Skip to content

Clinical trials

Adenocarcinoma trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Country / region: Israel Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111
20141
20151
20162
20182
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anchiano Therapeutics Israel Ltd.1
Astellas Pharma Global Development, Inc.1
Daiichi Sankyo1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1
Famewave Ltd.1
Genzyme, a Sanofi Company1
Incyte Corporation1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma10
Carcinoma, Non-Small-Cell Lung5
Neoplasms4
Stomach Neoplasms4
Colorectal Neoplasms3
Colonic Neoplasms2
Adenocarcinoma of Lung1
Breast Neoplasms1
Carcinoma, Ductal1
Carcinoma, Large Cell1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.